WASHINGTON — The U.S. Food and Drug Administration on Thursday approved an updated COVID-19 vaccine intended to address severe symptoms of the virus ahead of the cold and flu season. The new booster shots from Moderna and Pfizer follow a summer of increasing COVID-19 cases and are designed to better address the variants that are […]
